文献速递心外重症与机械循环支持

临时性右心室机械循环支持的临床经验

Clinical experience with temporary right ventricular mechanical circulatory support.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-05-01

该回顾性研究分析80例接受右心室辅助装置的患者,适应证为心脏切开术后心源性休克13例(16%)、心脏移植25例(31%)、左心室辅助装置置入42例(53%)。心脏切开术后心源性休克组脱机率46%,低于心脏移植组84%和左心室辅助装置组83%;立即支持组3个月生存率79%优于延迟支持组46%(P=0.003)。心脏切开术后心源性休克是脱机的独立负性预测因素(OR 0.161,P=0.007)。

要点

  • 心脏切开术后心源性休克患者脱机率46%,低于心脏移植84%和左心室辅助装置83%。
  • 立即支持组3个月生存率79%优于延迟支持组46%(P=0.003)。
  • 心脏切开术后心源性休克是脱机失败的独立负性预测因素(OR 0.161,P=0.007)。

核心结论

  • 临时性右心室机械支持仍是左心室辅助装置置入后的有效治疗策略,立即支持可带来更优的短期生存。
  • 心脏切开术后心源性休克患者脱机率和生存率均较差,应谨慎对待。
  • 总体生存结局随时间推移保持相对稳定。

研究设计与样本

  • 回顾性综述,数据来自前瞻性维护的数据库,纳入80例接受右心室辅助装置的患者。
  • 采用Kaplan-Meier生存分析比较组间生存,多因素回归分析确定脱机失败的危险因素。

主要发现

  • 支持适应证为心脏切开术后心源性休克13例(16%)、心脏移植25例(31%)、左心室辅助装置42例(53%)。
  • 中位支持时间6天;脱机成功分别为心脏切开术后心源性休克6例(46%)、心脏移植21例(84%)、左心室辅助装置35例(83%)。
  • 心脏切开术后心源性休克患者生存劣于左心室辅助装置患者。
  • 立即支持组(n=43)3个月生存率79%优于延迟支持组(n=37)的46%(P=0.003)。

临床怎么用

  • 作者认为临时性右心室机械支持仍是左心室辅助装置置入后的有效治疗策略,立即支持可带来更优的短期生存。
  • 作者建议在心脏切开术后心源性休克患者中谨慎应用,因其脱机率和生存率均较差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study sought to determine if indication for support affects the outcomes after temporary right ventricular mechanical circulatory support after postcardiotomy cardiogenic shock, cardiac transplant, or left ventricular assist device placement. METHODS: A retrospective review was performed on 80 patients receiving a right ventricular assist device. Data were collected from a prospectively maintained database. Kaplan-Meier survival analysis was performed to compare survival between groups. Multivariate regression analysis was performed to identify risk factors for failure to wean from support. RESULTS: The indication for support was postcardiotomy cardiogenic shock in 13 patients (16%), cardiac transplant in 25 patients (31%), and left ventricular assist device in 42 patients (53%). Median support time was 6 days. Device was successfully weaned in 6 postcardiotomy cardiogenic shock cases (46%), 21 cardiac transplant cases (84%), and 35 left ventricular assist device cases (83%). Survival was worse for patients with postcardiotomy cardiogenic shock compared with patients with a left ventricular assist device. Survival up to 3 months was better for patients who received immediate (n = 43) versus delayed (n = 37) support (79% vs 46%, P = .003). Weaning and survival remained static across implant era. Risk factor analysis identified postcardiotomy cardiogenic shock indication (odds ratio, 0.161; P = .007; confidence interval, 0.043-0.600) as an independent negative predictor of weaning from mechanical support. CONCLUSIONS: Temporary right ventricular mechanical support remains an effective treatment strategy after left ventricular assist device placement with immediate support resulting in superior short-term survival. Caution should be applied in postcardiotomy cardiogenic shock when weaning and survival are poor. Overall survival outcomes have remained relatively static over time.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bhama JK, Bansal U, Winger DG, et al. Clinical experience with temporary right ventricular mechanical circulatory support. J Thorac Cardiovasc Surg. 2018. PMID: 29861112. doi:10.1016/j.jtcvs.2018.04.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。